Your browser doesn't support javascript.
loading
Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study.
Sandau, Ursula S; Duggan, Erika; Shi, Xiao; Smith, Sierra J; Huckans, Marilyn; Schutzer, William E; Loftis, Jennifer M; Janowsky, Aaron; Nolan, John P; Saugstad, Julie A.
Afiliación
  • Sandau US; Department of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA.
  • Duggan E; Scintillon Institute San Diego California USA.
  • Shi X; VA Portland Health Care System Portland Oregon USA.
  • Smith SJ; Department of Psychiatry Oregon Health & Science University Portland Oregon USA.
  • Huckans M; Methamphetamine Research Center Oregon Health & Science University Portland Oregon USA.
  • Schutzer WE; Department of Behavioral Neuroscience Oregon Health & Science University Portland Oregon USA.
  • Loftis JM; Department of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA.
  • Janowsky A; VA Portland Health Care System Portland Oregon USA.
  • Nolan JP; Department of Psychiatry Oregon Health & Science University Portland Oregon USA.
  • Saugstad JA; Methamphetamine Research Center Oregon Health & Science University Portland Oregon USA.
J Extracell Vesicles ; 10(1): e12028, 2020 11.
Article en En | MEDLINE | ID: mdl-33613872
Methamphetamine (MA) is the largest drug threat across the globe, with health effects including neurotoxicity and cardiovascular disease. Recent studies have begun to link microRNAs (miRNAs) to the processes related to MA use and addiction. Our studies are the first to analyse plasma EVs and their miRNA cargo in humans actively using MA (MA-ACT) and control participants (CTL). In this cohort we also assessed the effects of tobacco use on plasma EVs. We used vesicle flow cytometry to show that the MA-ACT group had an increased abundance of EV tetraspanin markers (CD9, CD63, CD81), but not pro-coagulant, platelet-, and red blood cell-derived EVs. We also found that of the 169 plasma EV miRNAs, eight were of interest in MA-ACT based on multiple statistical criteria. In smokers, we identified 15 miRNAs of interest, two that overlapped with the eight MA-ACT miRNAs. Three of the MA-ACT miRNAs significantly correlated with clinical features of MA use and target prediction with these miRNAs identified pathways implicated in MA use, including cardiovascular disease and neuroinflammation. Together our findings indicate that MA use regulates EVs and their miRNA cargo, and support that further studies are warranted to investigate their mechanistic role in addiction, recovery, and recidivism.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Relacionados con Anfetaminas / Vesículas Extracelulares / MicroARN Circulante / Metanfetamina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Extracell Vesicles Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Relacionados con Anfetaminas / Vesículas Extracelulares / MicroARN Circulante / Metanfetamina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Extracell Vesicles Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos